Showing all 4 results
Bisacodyl Tablets
FreeProduct Composition & Strength
We supply this product as Enteric Coated Tablets (Gastro-resistant). The specialized coating is non-negotiable to prevent gastric irritation.
Active Ingredient Strength (Standard) Formulation Type Primary Role Bisacodyl USP/BP 5 mg Enteric Coated (Sugar or Film) Standard Adult Dose Bisacodyl USP/BP 10 mg Enteric Coated Strong Dose / Bowel Prep Excipients Q.S. Methacrylic Acid Copolymer (Enteric) pH-Dependent Release Ulipristal Acetate Tablets
FreeProduct Composition & Strength
We supply this product as a Film-Coated or Uncoated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips, optimized for both single-dose retail dispensing and chronic gynecological therapy.
Active Ingredient Strength Primary Clinical Use Ulipristal Acetate INN/Ph.Eur. 30 mg Emergency Contraception: Single-dose therapy taken within 120 hours of unprotected intercourse. Ulipristal Acetate INN/Ph.Eur. 5 mg Uterine Fibroids: Chronic daily dosing for pre-operative management of moderate-to-severe fibroid symptoms. Excipients Lactose Monohydrate / Povidone / Croscarmellose Sodium Diluent / Binder / Superdisintegrant (Ensures rapid gastric dispersion for urgent absorption) Varenicline Tablets
FreeProduct Composition & Strength
We supply this product as a Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips. We specifically offer the globally mandated “Titration Starter Packs” to ensure patient compliance during the critical first two weeks of therapy.
Active Ingredient Strength Primary Clinical Use Varenicline Tartrate INN/USP 0.5 mg Mandatory dose-titration initiation (Days 1 through 7 of the quit attempt). Varenicline Tartrate INN/USP 1 mg Standard Adult Maintenance Dose (Day 8 through Week 12 or 24). Excipients Microcrystalline Cellulose / Anhydrous Dibasic Calcium Phosphate / Croscarmellose Sodium Diluent / Superdisintegrant (Ensures rapid, uniform gastric dispersion)




